Back to Search
Start Over
Genetic and environmental risk factors for oral anticoagulant overdose.
- Source :
-
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2003 Mar; Vol. 58 (11), pp. 739-45. Date of Electronic Publication: 2003 Feb 18. - Publication Year :
- 2003
-
Abstract
- Background: Cytochrome P450 2C9 (CYP2C9) allelic variant carriers have been shown to experience hyper-responsiveness to small doses of oral anticoagulants (OAs) (warfarin or acenocoumarol) and a higher bleeding rate.<br />Objectives: To determine the relative frequencies of different risk factors for OA overdose including diet, concomitant diseases, drug interactions, recent increment of OA dose and CYP2C9 genetic polymorphism among hospitalised patients.<br />Materials and Methods: Frequencies of the different risk factors for OA overdose were determined in a prospective case-control study. Seventy-five consecutive patients with an International normalised ratio (INR) greater than 4 were matched with seventy-five control patients with an INR greater than 2 but less than 3.5 with respect to age, prescribed OA and daily dose. Genotyping of CYP2C9*2 and CYP2C9*3 allelic variants was detected by the TaqMan allelic discrimination assay.<br />Results: Drug interactions and a recent increment of OA dose were the only significant independent risk factors identified in the first analysis with odds ratio 2.13 (95% CI: 1.06-4.28) and 3.38 (95%CI: 1.51-7.57), respectively. A recent increment of OA dose was the only significant independent risk factor identified among the patients treated with coumarin derivatives (acenocoumarol or warfarin), excluding those treated with fluindione; the odds ratio was 4.3 (95% CI: 1.5-12.3). CYP2C9 genetic polymorphism did not significantly predict the increased risk of OA overanticoagulation in this study. However three homozygous CYP2C9*3/CYP2C9*3 genotype patients were found among the cases, whereas no such patients could be identified among controls.<br />Conclusion: This is the first observational study investigating the role of CYP2C9 genetic polymorphism together with other environmental OA overdose risk factors. Our results support the view that although the CYP2C9*3/CYP2C9*3 genotype is associated soon after the introduction of OA with dramatic overanticoagulation, OA overdose is mostly related to environmental factors.
- Subjects :
- Administration, Oral
Aged
Anticoagulants pharmacokinetics
Aryl Hydrocarbon Hydroxylases genetics
Case-Control Studies
Cytochrome P-450 CYP2C9
Dose-Response Relationship, Drug
Drug Interactions
Drug Overdose
Female
Food-Drug Interactions
Genotype
Hemorrhage chemically induced
Humans
Inpatients
International Normalized Ratio
Male
Mutation
Polymorphism, Genetic
Prospective Studies
Risk Factors
Vitamin K administration & dosage
Anticoagulants administration & dosage
Anticoagulants adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 0031-6970
- Volume :
- 58
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- European journal of clinical pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 12634980
- Full Text :
- https://doi.org/10.1007/s00228-002-0538-2